Skip to main navigation
LinkedIn Twitter
  • Investors
  • Careers
Outlook Therapeutics, Inc. Logo
  • About
    • Overview
    • Senior Leadership
    • Board of Directors
  • Pipeline
    • Overview
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • UNMET NEEDS
  • News
  • Contact

SEC Filings

Home / Investors / SEC Filings / SCHEDULE 13D/A

SEC Filing Details

Document Details

Form
SCHEDULE 13D/A
Filing Date
Mar 12, 2025
Document Date
Mar 12, 2025
Form Description
SCHEDULE 13D/A - Description
Company
Outlook Therapeutics, Inc.
Issuer
OUTLOOK THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Other Shareholder Information
  • Financial Information
    • SEC Filings
  • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Presentations
  • Corporate Governance
    • Governance Highlights
    • Board Diversity Disclosure
    • Senior Leadership
    • Board of Directors
    • Committee Composition
  • Information Request
  • Print Page Print Page
  • Email Page Email Page
  • RSS Feeds RSS Feeds
  • Email Alerts Email Alerts
  • Contact IR Contact IR
© 2018-2026 Outlook Therapeutics, Inc.
This site is intended for a US audience only.
Privacy Policy | Disclaimer | Terms of use